The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The mechanisms leading to degeneration of dopaminergic neurons (DNs) in the substantia nigra of patients with Parkinson's disease (PD) are not completely understood. Here, we show, in the postmortem human tissue, that these neurons aberrantly express mitosis-associated proteins, including the E2F-1 transcription factor, and appear to duplicate their nuclear DNA. We further demonstrate that the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injected into mice and application of its active metabolite 1-methyl-4-phenylpyridinium to mesencephalic cultures activate the retinoblastoma–E2F pathway in postmitotic DNs. We also find that cell death rather than mitotic division followed the toxin-induced replication of DNA, as determined by BrdU incorporation in DNs. In addition, blocking E2F-1 transcription protected cultured DNs against 1-methyl-4-phenylpyridinium toxicity. Finally, E2F-1-deficient mice were significantly more resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic cell death than their wild-type littermates. Altogether, BrdU incorporation in mature neurons and lack of evidence for newborn neurons argue against neuronal turnover in normal conditions or during pathological states in the substantia nigra. Instead, our results demonstrate that mitosis-like signals are activated in mature DNs in patients with PD and mediate neuronal death in experimental models of the disease. Inhibition of mitosis-like signals may therefore provide strategies for neuroprotection in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study reported increased levels of the E2F-1 transcription factor in dopaminergic neurons in the substantia nigra of PD patients and suggested that the pRb/E2F-1 pathway is activated in these neurons which can lead to apoptosis [251].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [251]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation
Field, S. J., Tsai, F.-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., & Greenberg, M. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81255-6 · Cited by 754
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D. S., & Herrup, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 616
The harlequin mouse mutation downregulates apoptosis-inducing factor
Klein, J. A., Longo-Guess, C. M., Rossmann, M. P., Seburn, K. L., Hurd, R. E., Frankel, W. N., Bronson, R. T., & Ackerman, S. L. (2002) · Nature · doi:10.1038/nature01034 · Cited by 605
Evidence for neurogenesis in the adult mammalian substantia nigra
Zhao, M., Momma, S., Delfani, K., Carlén, M., Cassidy, R. M., Johansson, C. B., Brismar, H., Shupliakov, O., Frisén, J., & Janson, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131955100 · Cited by 590
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483
The Adult Substantia Nigra Contains Progenitor Cells with Neurogenic Potential
Lie, D. C., Dziewczapolski, G., Willhoite, A. R., Kaspar, B. K., Shults, C. W., & Gage, F. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06639.2002 · Cited by 449
Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., & Abeliovich, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00084-9 · Cited by 381
Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley, S., Mount, M. P., O'Hare, M. J., Callaghan, S., Slack, R. S., Przedborski, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232515100 · Cited by 319
The genetics of the E2F family of transcription factors: shared functions and unique roles
DeGregori, J. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00051-3 · Cited by 295
Self-citation
Cited by
Items 201–277 of 277
RETRACTED: Protective effect of roscovitine against rotenone-induced parkinsonism
Chen, Y., Hou, Y., Ge, R., Han, J., Xu, J., Chen, J., & Wang, H. (2018) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-180817 · Cited by 7
“Studies have verified that aberrant cell cycle regulation contributed to neuronal degeneration and death in both in vivo and in vitro PD models (H¨oglinger et al., 2007).”
InfluentialRetractedNeuronal Cell Cycle Events Link Caloric Intake to Obesity
Iqbal, N. J., Zhu, L., & Chua, S. C. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.09.001 · Cited by 7
“Similar to AD patients, a certain degree of cell cycle reentry is seen in the dysfunctional neurons of PD patients as well, as evidenced by DNA content, pRb phospho-inactivation, and E2F1 target gene expression [34].”
BackgroundZhang, Z., Wang, T., Cao, X., Sun, S., & Wang, L. (2009) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-009-0121-5 · Cited by 7
“Thus, the RB protein seems to be indispensable for the maintenance of the postmitotic state of terminally differentiated neurons [15] . At the G1/S checkpoint in cell cycle, the cell cycle complexes cause the phosphorylation of RB and allow the release of transcriptional factors [ 16 , 17] . Thus, the phosphorylation…”
BackgroundDiscovery of cancer-preventive juices reactivating RB functions
Masuda, M., Horinaka, M., Yasuda, S., Morita, M., Nishimoto, E., Ishikawa, H., Mutoh, M., & Sakai, T. (2023) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.23-00160 · Cited by 6
Navarro, E., Efthymiou, A. G., Mattei, D., Parks, M., Riboldi, G. M., Vialle, R. A., Udine, E., Muller, B. Z., Humphrey, J., Allan, A., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03967-0 · Cited by 5
Dutta, S., Chakraborty, S., Ghosh, A., Halder, P., Majumder, S., Paul, R., Nath, S., & Mukherjee, P. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110695 · Cited by 6
“Mature DNs in the substantia nigra (SNc) also show aberrant cell cycle reactivation in PD. Postmortem brain analyses of DN of patients with PD reveal increased phosphorylation of retinoblastoma protein (pRb), a key regulator of G1-S phase transition (24).”
Cerro, P. D., Alquézar, C., Bartolomé, F. B., González-Naranjo, P., Pérez, C., Carro, E., Paez, J. A., Campillo, N. E., & Martín‐Requero, Á. (2018) · CNS Drugs · doi:10.1007/s40263-018-0515-7 · Cited by 7
Duran‐Vilaregut, J., Manich, G., del Valle, J., Pallàs, M., Camins, A., Pelegrí, C., & Vilaplana, J. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.07.009 · Cited by 6
Association between rs823128 polymorphism and the risk of Parkinson’s disease: A meta-analysis
Cai, M., Liu, Z., Li, W., Wang, Y., & Xie, A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.057 · Cited by 6
“It is worth noting that a previous research indicated that cell-cycle protein mediated the degeneration of dopaminergic neurons [30,31].”
BackgroundPathways of protein synthesis and degradation in PD pathogenesis
Langston, R. G., & Cookson, M. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.01.002 · Cited by 9
Cell Cycle Proteins and Retinal Degeneration: Evidences of New Potential Therapeutic Targets
Arsenijévic, Y. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_49 · Cited by 6
Casey, A., Liu, W., Hein, L. K., Sargeant, T. J., Pederson, S., & Mäkinen, V. (2022) · Scientific Reports · doi:10.1038/s41598-022-21617-2 · Cited by 7
“relationships, but we speculate that E2F transcription factors respond to age-associated metabolic dysfunction and may subsequently trigger neuronal apoptosis [56,57].”
BackgroundDas, A. K., & Biswas, S. C. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119848 · Cited by 9
Cell cycle events mediate lactacystin‐induced apoptotic death of neuronal PC12 cells
Zhang, Z., Xu, Y., Qin, K., Wang, T., & Cao, X. (2010) · Cell Biology International · doi:10.1042/cbi20090079 · Cited by 5
“However, the aberrant expression of cell cycle markers was evident in postmitotic neurons in several neurodegenerative diseases, including PD and AD (Alzheimer’s disease) (Höglinger et al., 2007; Mosch et al., 2007).”
BackgroundMethodInfluentialTesting the Neuroprotective Properties of PCSO-524® Using a Neuronal Cell Cycle Suppression Assay
Zhu, B., Zhang, Y., & Herrup, K. (2019) · Marine Drugs · doi:10.3390/md17020079 · Cited by 6
“This life-long prohibition against cell division can be seen most dramatically in a variety of neurodegenerative diseases, including Alzheimer’s disease [1–3], ataxia telangiectasia [4], Parkinson’s disease [5], and others.”
BackgroundGao, Y., Takenaka, K., Santucci, K., Lindner, G., Xu, S.-M., Cheng, Y., & Janitz, M. (2025) · Molecular Brain · doi:10.1186/s13041-025-01262-2 · Cited by 5
“Höglinger et al. [58] revealed the mitosis-associated proteins E2F-1 transcription factor were activated and its chromosome aberrantly duplicated in mature dopaminergic neurons from PD patients.”
Aging entails distinct requirements for Rb at maintaining adult neurogenesis
Omais, S., Hilal, R. N., Halaby, N. N., Jaafar, C., & Ghanem, N. (2022) · Aging Brain · doi:10.1016/j.nbas.2022.100041 · Cited by 4
“Moreover, Rb dysregulation was linked to neuronal abnormalities and pathogenesis of neurodegenerative diseases in human postmortem tissues [29,31,33,45].”
BackgroundGenetic modifiers of synucleinopathies—lessons from experimental models
Lee, R. M. Q., & Koh, T. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvad001 · Cited by 6
“Dysregulation of the cell cycle has been demonstrated in synu-cleinopathiesandinPDmodels[256–259].”
BackgroundHuang, B., Huang, H., Zhang, Z., Liu, Z., Luo, J., Liu, M., & Luo, T. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13090 · Cited by 4
2′,3′-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
Niu, J., Xiong, J., Hu, D., Zeng, F., Nie, S., Mao, S., Wang, T., Zhang, Z., & Zhang, Z. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2330-9 · Cited by 4
“For example, some of the vulnerable neurons from PD and AD patients are polyploid, indicating they have finished at least part of the DNA replication [3, 6].”
Baratchi, S., Kanwar, R. K., & Kanwar, J. R. (2011) · PLoS ONE · doi:10.1371/annotation/c6435c2d-0692-476f-8795-d8e49421cd3c · Cited by 4
Fortunato, A. (2008) · Genomics · doi:10.1016/j.ygeno.2008.11.006 · Cited by 4
Nuclear Alpha‐Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
Jiménez-Capdeville, M. E., Chi-Ahumada, É., García-Ortega, F., Castanedo-Cázares, J. P., Norman, R. A., & Rodríguez‐Leyva, I. (2025) · Neurology Research International · doi:10.1155/nri/1119424 · Cited by 3
Cell Cycle and DNA Damage Response in Postmitotic Neurons
Kruman, I. I. (2011) · InTech eBooks · doi:10.5772/20859 · Cited by 4
“…to the dopaminergic cell neurotoxins 1-methyl-4-phenyl1,2,3,6-tertahydropyridine (MPTP) results in cell cycle activation in post-mitotic neurons prior to their subsequent death, while E2F1 deficiency leads to a significant resistance to MPTP-induced dopaminergic cell death (Hoglinger et al., 2007).”
BackgroundAddressing the Complex Etiology of Alzheimer‘s Disease: the Role of P25/Cdk5
Mungenast, A. E., & Tsai, L. (2011) · Future Neurology · doi:10.2217/fnl.11.22 · Cited by 3
“It has since become clear that, in neuropathologies involving neuronal loss, such as ischemic stroke [201–203], Parkinson’s disease [204,205], Huntington’s disease [206], amyotrophic lateral sclerosis [207,208] and AD [209–213], neurons engage in aberrant cell cycle activities, expressing cell cycle markers such as Ki…”
BackgroundColchicine as a promising drug for Parkinson’s disease
Salama, M., & Arias-Carrión, Ó. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.10.032 · Cited by 4
Mechanisms Underlying Long-Latency Neurodegenerative Diseases of Environmental Origin
Spencer, P. S., Salama, M., & Kisby, G. E. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_184 · Cited by 4
Jackson, D., Ting, J. H., Pozniak, P. D., Meurice, C., Schleidt, S. S., Dao, A., Lee, A. H., Klinman, E., & Jordan‐Sciutto, K. L. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.06.003 · Cited by 4
Thomaidou, D., Politis, P. K., & Matsas, R. (2010) · Springer eBooks · doi:10.1007/978-1-60327-153-0_8 · Cited by 4
“striatal dopaminergic neuron degeneration in the 6-hydroxy-dopamine (6-OHDA) chemical model of Parkinson’s disease (PD) in rodents impairs SVZ neural precursor generation most probably due to dopamine depletion [235], indicating that”
BackgroundNGF/P75 in Cell Cycle and Tetraploidy
López‐Sánchez, N., Ovejero-Benito, M. C., Rodríguez-Ruiz, C., & Frade, J. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_27 · Cited by 2
Fernández‐Espejo, E. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_16 · Cited by 2
“Neuronal death in PD can also be related to the induction of mitosis, as revealed by H ¨ oglinger and associates [44] who show that, in the postmortem human tissue, dopaminergic neurons aberrantly express mitosis-associated proteins, including the E2F-1 transcription factor, and appear to duplicate their nuclear DNA […”
BackgroundExpression of D-type cyclins in differentiating cells of the mouse spinal cord
Salles, P. D. A., Fortes, J. C., Guedes, M. I. F., & Weller, M. (2007) · Genetics and Molecular Biology · doi:10.1590/s1415-47572007000400032 · Cited by 3
“Additionally, expression of D-type cyclins has been implicated in neuronal cell death associated with seizure, ischemia, stress and neurodegenerative diseases (Becker and Bonni, 2005; Hoglinger et al., 2007).”
The Amyloid _-Protein and Alzheimer's Disease
Teplow, D. B., Yang, M., Roychaudhuri, R., Pang, E. S., Huynh, T. V., Chen, M., & Beroukhim, S. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-2 · Cited by 2
Purzner, J., Brown, A. S., Purzner, T., Ellis, L., Broski, S., Litzenburger, U. M., Andrews, K., Sharma, A., Wang, X., Taylor, M. D., et al. (2025) · eLife · doi:10.7554/elife.105339.1 · Cited by 2
CDK3 induces neuronal death and brain atrophy in Alzheimer’s disease
Zhuang, K., Zi, L., Su, X., Chen, H., Li, X., Wang, S., Xia, Y., Wu, B., Su, Y., Chen, S., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01026-6 · Cited by 2
“…diseases apart from AD (for example, amyotrophic lateral sclerosis, ataxia telangiectasia, Parkinson’s disease); neuronal cell cycle protein re-expression has been found in each of their mouse models, yet none of them has replicated the neuronal cell death observed in humans 55–57 .”
Significance of Retinoblastoma Protein in Survival and Differentiation of Cerebellar Neurons
Padmanabhan, J. (2012) · InTech eBooks · doi:10.5772/32102
“In addition to its function in control of cell cycle, Rb has been shown to be important in development and survival of neurons (Athanasiou et al., 1998; Feddersen et al., 1995; Feddersen et al., 1997; Hoglinger et al., 2007; Padmanabhan et al., 2007).”
BackgroundYeger‐Lotem, E., Riva, L., Su, L. J., Gitler, A. D., Cashikar, A. G., King, O. D., Auluck, P. K., Geddie, M. L., Valastyan, J. S., Karger, D. R., et al. (2009) · Cited by 1
Rb deficiency induces p21cip1 expression and delays retinal degeneration in rd1 mice
Lv, Z., Xiao, L., Tang, Y., Chen, Y., & Chen, D. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108701 · Cited by 3
Gal-Ben-Ari, S., & Youdim, M. B. H. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_211 · Cited by 1
Zhang, J. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Creating a protein-protein interaction network for alpha-synuclein
Könn, M. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7491 · Cited by 3
Purzner, J., Brown, A. S., Purzner, T., Ellis, L., Broski, S., Litzenburger, U. M., Andrews, K., Sharma, A., Wang, X., Taylor, M. D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.21.624171 · Cited by 2
Neuronal cell-cycle re-entry stratifies clinical trajectories in amyotrophic lateral sclerosis
Plessis‐Belair, J., & Sher, R. B. (2026) · Brain · doi:10.64898/2026.02.13.705790 · Cited by 1
Cdk5 May Be an Atypical Kinase, but Not in the Way You Think
Wang, L., Zhang, J., & Herrup, K. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_9
“While ensuring this block to future division might seem to be primarily a problem of differentiation rather than cell cycle regulation, accumulating evidence suggests that the neuron must constantly suppress the cell cycle process in order to remain in the post-mitotic state throughout life (reviewed in Herrup and Yan…”
BackgroundSelimoivic, D., Ghozlan, H. A., Haïkel, Y., & Hassan, M. (2008) · Journal of Hepatology · doi:10.1016/s0168-8278(08)60592-9
Brederlau, A. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Investigation of the genetic aetiology of Parkinson's disease in South Africa
Keyser, R. J. (2011) · SUNScholar (Stellenbosch University) · Cited by 2
Donaires, F. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-26092011-111938
Zebrafish as a translational model of Parkinson's disease : a study of microRNAs
Trollope, L. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Vázquez-Villaseñor, I. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Machine learning discriminates parkinsonian movement disorders in zebrafish
Hughes, G. L. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Intralipid as a novel Autophagy Inducer Target for Neurotoxic Effects of Rotenone
Abdel-Razik, E. A., El-Bakary, A., Shaaban, S., El-Desouky, S., & EL-Mansoury, A. (2020) · Mansoura Journal of Forensic Medicine and Clinical Toxicology · doi:10.21608/mjfmct.2020.41492.1022
Ting, J. H. (2014) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
Posttranslational modifications of TDP-43
Rahman, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820066-7.20002-7
Mechanisms Underlying Long-Latency Neurodegenerative Diseases of Environmental Origin
Spencer, P. S., Salama, M., & Kisby, G. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_184-1 · Cited by 1
Gal-Ben-Ari, S., & Youdim, M. B. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_211-1
Podocyte Mitosis - A Catastrophe
Lasagni, L., Lazzeri, E., Shankland, S. J., Anders, H., & Romagnani, P. (2013) · Current Molecular Medicine · doi:10.2174/15665240113138880020 · Cited by 8
Identification of hub genes and key pathways in spinal cord injury via bioinformatics analysis
Cheng, H., Wang, Y., & Xuan, J. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.3.9
“…is reported to be involved in the pathophysiologic process of neurodegene - rative disorders such as Parkinson’s disease and Alzhei - mer’s disease (30, 31), and it is also suggested to regulate the neuronal apoptosis and glial proliferation/activation after central nervous system (CNS) injury,…”
BackgroundPurzner, J., Brown, A. S., Purzner, T., Ellis, L., Broski, S., Litzenburger, U. M., Andrews, K., Sharma, A., Wang, X., Taylor, M. D., et al. (2025) · eLife · doi:10.7554/elife.105339
Prognostic and biological roles of Parkinson’s disease genes in cancerPreprint
Fiume, S., Molinari, F., Vai, B., Poletti, S., Citterio, G., Fiumara, F., Papin, S., Paganetti, P., Callari, M., & Colnaghi, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.22.644759
“Moreover, in diseases like PD and AD, neuronal cells—typically maintained in the G0 phase—can aberrantly reenter the cell cycle, ultimately undergoing mitotic catastrophe (44 and 45).”
Ageing of neural stem cells in a Parkinson's disease Model
Menzl, I. (2013) · University of Vienna · doi:10.25365/thesis.27046
Marques, M. B. S. S., Guedes, A., Vasilevskiy, I., Gonçalves, S., Outeiro, T. F., Winderickx, J., Burhans, W. C., & Ludovico, P. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Wang, L., Zhang, B., Yan, Y., Yang, X., Zhang, L., Bi, L., Sang, Y., Li, D., & Bi, X. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-025-02612-2
“Although aberrant expression and activation of the E2f1 transcription factor was observed in patients with neurodegenerative disorders [17–19], whether the E2f1 is required for the central nervous system (CNS) development is still not clear.”
Valverde-Guillén, P., Seoane, P., Ranea, J. A. G., Medina, M. Á., Marí-Beffa, M., García-Díaz, B., & Bernal-Quirós, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.09.710294
“E2F1 is involved in several NDDs such as Alzheimer 57 and Parkinson´s disease 58 , primarily due to its role in cell cycle regulation, apoptosis, and neuronal cell death.”
Rôle du corégulateur transcriptionnel RIP140 dans la signalisation par les facteurs E2Fs
Docquier, A. (2010) · theses.fr (ABES) · doi:10.70675/64f8d2cdzd236z48fdz8294z6cfdebdb2fd9
Failure of DNA double-strand break repair by tau mediates Alzheimer's disease pathology in vitro
浅田, め., 南山, 素., 引網亮太, 守村敏史, 小代, 明., 漆谷, 真., Asada‐Utsugi, M., Uemura, K., Ayaki, T., Uemura, M. T., et al. (n.d.) · Institutional Repositories DataBase (IRDB)
Sroyraya, M., Noonong, K., Sobhon, P., Siangcham, T., Waiyaput, W., Sansri, V., Chaithirayanon, K., & Chonpathompikunlert, P. (2026) · Molecules · doi:10.3390/molecules31071175
“…mice) received 4 IP injections of MPTP solution (15 mg/kg body weight per injection) in a volume of 1 mL/100 g body weight, at 2-h intervals; and Group III (sub-acute MPTP-induced mice) received 5 IP injections of MPTP solution (25 mg/kg body weight per injection) at 24-h intervals [52–54].”
Mitochondrial Fission and Fusion Disorders and Autophagy Abnormalities in Parkinson’s Disease
Liu, Y., Li, H., & Bai, J. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04752-4
Interaction between Poly(ADP-ribose) polymerase-1 and α-synuclein pathology in Parkinson’s disease
Zhang, P., 李清华, Diao, X., & Zeng, S. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1774158
Cyclin-dependent kinases in neurodegenerative disorders
Saito, T., & Ando, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44173-8.00018-8
Ying, J., Fang, Z., Zhang, C. L., Liu, X., Cui, J., Li, Z., & Tang, J. (2026) · Health care science · doi:10.1002/hcs2.70087
G3BP1 depletion, observed in Parkinson’s Disease, drives Golgi–lysosome–autophagy defects
Ramakrishna, S., Ryan, L., Son, S. M., & Rubinsztein, D. C. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01853-z
Dzomo, T., & Rodrigue, G. (2012) · Georgetown University-Graduate School of Arts & Sciences
Urbaczek, A. C. (2012) · Americanae (AECID Library)
The Effect of Different Microglial Activation States on the Survival of Retinal Ganglion Cells
Siddiqui, A. M. (2013) · MacSphere (McMaster University) · doi:10.71548/21084
Dissociated mesencephalic cultures
Escobar-Khondiker, M., Toulorge, D., Guerreiro, S., Hirsch, É. C., & Michel, P. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00030-0 · Cited by 1
Self-citation
Metadata
- Authors
- Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., Hirsch, E. C., & Hunot, S.
- Affiliations
- Inserm (FR)
- Yale University (US)
- Philipps University of Marburg (DE)
- *Department of Experimental Neurology, Philipps University, 35039 Marburg, Germany;
- University of Colorado Denver (US)
- Department of Experimental Neurology and Therapeutics, Unité Mixte de Recherche 679, Institut National de la Santé et de la Recherche Médicale, 75013 Paris, France;
- Corresponding author
- Rakic, Pasko
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-02-27
- Volume
- 104
- Issue
- 9
- Pages
- 3585-3590
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1805567
- OpenAlex
- W2092598865
- Cited by
- 276
- References
- 25
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 14 · 2020: 12 · 2019: 16 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 22 · 2014: 17 · 2013: 19 · 2012: 16
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission (LSHM-CT-2003-503330)
- Bundesministerium für Bildung und Forschung (01GO0201, BMBF-01GN0513, 01GN0513)
- National Institute of Mental Health (R24MH068855, R24MH68855)
- National Cancer Institute (R01CA077314)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, dopaminergic neurons, substantia nigra, retinoblastoma protein, E2F1, cell cycle, neuronal cell death, MPTP, MPP+, DNA replication, neuroprotection, postmitotic neurons
- MeSH terms
- Analysis of Variance, Animals, Chromatography, High Pressure Liquid, Gene Expression Regulation, Humans, Immunohistochemistry, Interneurons, Male, Mice, Inbred C57BL, Parkinson Disease, Substantia Nigra, Signal Transduction, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-Methyl-4-phenylpyridinium, Oligonucleotides, Antisense, Apoptosis, In Situ Hybridization, Mice, Knockout, E2F1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.